Dr. Reddy's Laboratories Limited (NSE:DRREDDY)

Dr. Reddy's Laboratories Revenue

In the fiscal year ending March 31, 2026, Dr. Reddy's Laboratories had annual revenue of 337.00B INR with 3.52% growth. Dr. Reddy's Laboratories had revenue of 75.46B in the quarter ending March 31, 2026, a decrease of -11.51%.

• Revenue: 337.00B
• Revenue Growth: +3.52%
• P/S Ratio: 3.24
• Revenue / Employee: 12.08M
• Employees: 27,811
• Market Cap: 1.09T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	337.00B	11.47B	3.52%
Mar 31, 2025	325.54B	46.37B	16.61%
Mar 31, 2024	279.16B	33.29B	13.54%
Mar 31, 2023	245.88B	31.49B	14.69%
Mar 31, 2022	214.39B	24.67B	13.00%
Mar 31, 2021	189.72B	15.12B	8.66%
Mar 31, 2020	174.60B	20.75B	13.49%
Mar 31, 2019	153.85B	11.82B	8.32%
Mar 31, 2018	142.03B	1.22B	0.87%
Mar 31, 2017	140.81B	-13.90B	-8.98%
Mar 31, 2016	154.71B	6.52B	4.40%
Mar 31, 2015	148.19B	16.02B	12.12%
Mar 31, 2014	132.17B	15.90B	13.68%
Mar 31, 2013	116.27B	19.53B	20.19%
Mar 31, 2012	96.74B	22.04B	29.51%
Mar 31, 2011	74.69B	4.42B	6.28%
Mar 31, 2010	70.28B	836.00M	1.20%
Mar 31, 2009	69.44B	19.44B	38.87%
Mar 31, 2008	50.01B	-79.27B	-61.32%
Mar 31, 2007	129.28B	80.94B	167.42%
Mar 31, 2006	48.34B	9.70B	25.10%
Mar 31, 2005	38.65B	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error